Sugar immunogens

Sugar immunogens

Disclosed are compositions and methods useful for inducing an immunogenic response in a subject or host. In particular, the compositions and methods may be directed to carbohydrate HIV vaccines and to methods of producing a carbohydrate HIV vaccine by introducing antigenic sugars into mimics of the...

Full description

Bibliographic Details
Main Authors:	Dwek, R, Scanlan, C, Dunlop, D, Mansab, F, Tully, S, Wentworth, P, Zitzmann, N
Format:	Patent
Published:	World Intellectual Property Ogranization 2009

Similar Items

Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
by: Dunlop, D, et al.
Published: (2009)

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
by: Dwek R, et al.
Published: (2009-10-01)

Exploiting the defensive sugars of HIV-1 for drug and vaccine design
by: Scanlan, C, et al.
Published: (2007)

Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
by: Dunlop, D, et al.
Published: (2008)

Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
by: Dunlop, D, et al.
Published: (2008)

Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
by: Dunlop, D, et al.
Published: (2010)

Emerging principles for the therapeutic exploitation of glycosylation.
by: Dalziel, M, et al.
Published: (2014)

Liposome treatment of viral infections
by: Dwek, R, et al.
Published: (2011)

Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody.
by: Scanlan, C, et al.
Published: (2007)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
by: Butters, T, et al.
Published: (2005)

Use of iminosugar derivatives to inhibit ion channel activity
by: Zitzmann, N, et al.
Published: (2004)

Therapeutic applications of imino sugars in lysosomal storage disorders.
by: Butters, T, et al.
Published: (2003)

Imino sugar therapy for type 1 Gaucher disease.
by: Priestman, D, et al.
Published: (2000)

Endoplasmic reticulum targeting liposomes
by: Pollock, S, et al.
Published: (2011)

Cholesterol level lowering liposomes
by: Pollock, S, et al.
Published: (2012)

Sugar-mediated ligand-receptor interactions in the immune system.
by: Rudd, P, et al.
Published: (2004)

The influence of different lipid environments on the structure and function of the hepatitis C virus p7 ion channel protein
by: Whitfield, T, et al.
Published: (2011)

The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy.
by: Luik, P, et al.
Published: (2009)

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
by: Zitzmann, N, et al.
Published: (1999)

Targeting glycosylation as a therapeutic approach.
by: Dwek, R, et al.
Published: (2002)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
by: Bonomelli, C, et al.
Published: (2011)

Prion glycoprotein: structure, dynamics, and roles for the sugars.
by: Rudd, P, et al.
Published: (2001)

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.
by: Pollock, S, et al.
Published: (2008)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
by: Pardo, M, et al.
Published: (2007)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
by: Gangadharan, B, et al.
Published: (2008)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
by: Gangadharan, B, et al.
Published: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
by: Gangadharan, B, et al.
Published: (2010)

Sugar-protein connectivity impacts on the immunogenicity of site-selective salmonella O-antigen glycoconjugate vaccines
by: Stefanetti, G, et al.
Published: (2010)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
by: Andersson, U, et al.
Published: (2004)

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
by: Astronomo, R, et al.
Published: (2008)

Combination therapy for treatment of viral infections
by: Jeffs, R, et al.
Published: (2009)

The Hepatitis C Virus E2p7 localization and topology in a recombinant system
by: Popescu, C, et al.
Published: (2009)

Iminosugar antivirals: the therapeutic sweet spot
by: Alonzi, D, et al.
Published: (2017)

Applying proteomics technology to platelet research.
by: García, A, et al.
Published: (2005)

Glycobiology against viruses: Antiviral drug discovery
by: Zitzmann, N, et al.
Published: (2006)

The pestivirus E(rns) glycoprotein interacts with E2 in both infected cells and mature virions.
by: Lazar, C, et al.
Published: (2003)

Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns)
by: Branza-Nichita, N, et al.
Published: (2004)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
by: Boomkamp, S, et al.
Published: (2010)

Automated glycofingerprinting strategy
by: Dwek, R, et al.
Published: (2006)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2007)